Skip to content
Austin Top 50
Author:
ReproNovo SA
REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION
July 6, 2026
REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD
March 20, 2026